DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xq8rc4/global_ulcerative) has announced the addition of the "Global Ulcerative Colitis Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Ulcerative Colitis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Ulcerative Colitis market. It covers active Ulcerative Colitis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Ulcerative Colitis - Disease Overview
2. Ulcerative Colitis Pipeline Overview
3. Ulcerative Colitis Phase 3 Clinical Trial Pipeline Insights
4. Ulcerative Colitis Phase 2 Clinical Trial Pipeline Insights
5. Ulcerative Colitis Phase 1 Clinical Trial Pipeline Insights
6. Ulcerative Colitis Preclinical Research Pipeline Insights
7. Ulcerative Colitis Discovery Stage Pipeline Insights
8. Ulcerative Colitis Drug Development Activities - Geographic Landscape
8.1. Ulcerative Colitis R&D Activities in North America
8.2. Ulcerative Colitis R&D Activities in Europe
9. Ulcerative Colitis Pipeline - Licensing Activities
For more information visit http://www.researchandmarkets.com/research/xq8rc4/global_ulcerative